FindTrial
Sign In

Buprenorphine Sublingual Product

DRUG4 trials

Sponsors

T. John Winhusen, PhD, Yale University

Conditions

Drug AbuseDrug Abuse in PregnancyDrug AddictionNeonatal Abstinence SyndromeNeonatal Opiate Withdrawal SyndromeNeonatal Opioid Withdrawal SyndromeOpioid-Related DisordersOpioid-use Disorder

Phase 2

Emergency Department-Initiated Buprenorphine Validation Network Trial
CompletedNCT04225598
Yale UniversityOpioid-use Disorder
Start: 2020-07-08End: 2024-12-06Updated: 2025-01-10

Phase 3

Medication Treatment for Opioid Use Disorder in Expectant Mothers
CompletedNCT03918850
T. John Winhusen, PhDDrug Abuse, Drug Abuse in Pregnancy, Drug Addiction +5
Start: 2020-07-21End: 2025-01-31Updated: 2026-06-04

Unknown Phase

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
CompletedNCT03911739
T. John Winhusen, PhDDrug Abuse, Drug Abuse in Pregnancy, Drug Addiction +5
Start: 2021-06-14End: 2024-12-30Updated: 2026-03-16
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
CompletedNCT03911466
T. John Winhusen, PhDDrug Abuse, Drug Abuse in Pregnancy, Drug Addiction +5
Start: 2020-07-21End: 2024-11-06Updated: 2026-03-16

Related Papers

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum
JAMA Internal Medicine2026-03-16
Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
JAMA2026-02-111 citations
Cigarette use and smoking cessation goals among pregnant women with opioid use disorder.
2025-12-20
Overdose risk profiles in pregnancy: Latent class analysis of pregnant individuals with opioid use disorder.
2025-09-25
Protocol Commentary for the SUCCESS (Successful Recruitment and Retention in a Randomized Controlled Trial of Pregnant Participants with Opioid Use Disorder) Study
Substance Use &amp Addiction Journal2025-07-11
Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial
BMJ Open2025-02-012 citations
Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal
JAMA Network Open2024-07-0825 citations